Literature DB >> 17620274

Determining dangerousness in sexually violent predator evaluations: cognitive-experiential self-theory and juror judgments of expert testimony.

Joel D Lieberman1, Daniel A Krauss, Mariel Kyger, Maribeth Lehoux.   

Abstract

Past research examining the effects of expert testimony on the future dangerousness of a defendant in death penalty sentencing found that jurors are more influenced by less scientific clinical expert testimony and tend to devalue scientific actuarial testimony. This study was designed to determine whether these findings extend to civil commitment trials for sexual offenders and to test a theoretical rationale for this effect. In addition, we investigated the influence of a recently developed innovation in risk assessment procedures, Guided Professional Judgment (GPJ) instruments. Consistent with a cognitive-experiential self-theory based explanation, mock jurors motivated to process information in an experiential condition were more influenced by clinical testimony, while mock jurors in a rational mode were more influenced by actuarial testimony. Participants responded to clinical and GPJ testimony in a similar manner. However, participants' gender exerted important interactive effects on dangerousness decisions, with male jurors showing the predicted effect while females did not. The policy implications of these findings are discussed. 2007 John Wiley & Sons, Ltd

Entities:  

Mesh:

Year:  2007        PMID: 17620274     DOI: 10.1002/bsl.771

Source DB:  PubMed          Journal:  Behav Sci Law        ISSN: 0735-3936


  2 in total

Review 1.  [Sadistic fetishism--deadly passion. Forensic psychiatric assessment of sex offenders].

Authors:  N Nedopil; I Blümcke; H Bock; B Bogerts; C Born; S Stübner
Journal:  Nervenarzt       Date:  2008-11       Impact factor: 1.214

2.  In the eye of the beholder: Decision-making of lawyers in cases of sexual harassment.

Authors:  Liza Zvi; Mally Shechory-Bitton
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.